HERG篩檢市場規模、佔有率和成長分析（按類型、離子通道、應用和地區）- 產業預測 2025-2032

2023 年全球 HERG篩檢市場規模價值 16 億美元，預計將從 2024 年的 17.9 億美元成長到 2032 年的 43.7 億美元，預測期內（2025-2032 年）的複合年成長率為 11.8%。

近年來，由於對藥物安全的日益重視和對更有效的篩檢方法的需求，全球 HERG篩檢市場一直經歷持續成長。製藥和生物技術產業引領這個市場，並不斷尋求可靠的技術來降低藥物引起心律不整的風險。人們對藥物心臟毒性的認知不斷提高，凸顯了 HERG篩檢在藥物開發中的重要角色。自動膜片鉗系統和高通量篩檢等技術進步正在刺激市場擴張。藥品安全監管要求的日益嚴格迫使製藥公司投資 HERG篩檢解決方案，但高昂的前期成本對中小企業來說是一個挑戰。此外，準確預測藥物的心臟安全性仍然很複雜，需要持續研究來增強預測模型。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析

HERG篩檢市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 基因 KCNH2
• 突變型 KCNH2

HERG篩檢市場規模（依離子通道和複合年成長率） (2025-2032)

• 市場概況
• 電壓門
• 配體門

HERG篩檢市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 抗心律不整藥物
• 抗發炎藥物
• 抗生素
• 其他

HERG篩檢市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Cytocentrics AG（Germany）
• Charles River Laboratories（US）
• Thermo Fisher Scientific Inc.（US）
• PerkinElmer Inc.（US）
• Eurofins Scientific SE（Luxembourg）
• Nanion Technologies GmbH（Germany）
• SB Drug Discovery（UK）
• B'SYS GmbH（Switzerland）
• RedShift BioAnalytics, Inc.（US）
• Icagen, Inc.（a division of Eurofins DiscoverX）（US）
• Apredica（a division of Eurofins DiscoverX）（US）
• Inotrem SA（France）
• Axxam SpA（Italy）
• Ncardia AG（Germany）

結論和建議

Global HERG Screening Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.79 billion in 2024 to USD 4.37 billion by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032).

The global hERG screening market has seen consistent growth in recent years, driven by the increasing emphasis on drug safety and the demand for more efficient screening methods. The pharmaceutical and biotechnology sectors lead this market, continually seeking reliable technologies to mitigate the risk of drug-induced cardiac arrhythmias. Heightened awareness of drug cardiotoxicity has underscored the critical role of hERG screening in drug development. Advancements in technologies, such as automated patch clamp systems and high-throughput screening, are fueling market expansion. Stricter regulatory demands for drug safety compel pharmaceutical companies to invest in hERG screening solutions, although high initial costs pose challenges for smaller firms. Additionally, accurately predicting a drug's cardiac safety profile remains complex, necessitating ongoing research to enhance predictive models.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Herg Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global HERG Screening Market Segmental Analysis

Global HERG Screening Market is segmented by Type, Ion Channel, Application and region. Based on Type, the market is segmented into Gene KCNH2 and Mutant KCNH2. Based on Ion Channel, the market is segmented into Voltage-Gated and Ligand-Gated. Based on Application, the market is segmented into Antiarrhythmic, Antiphyshotic, Antibiotics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global HERG Screening Market

One of the primary catalysts driving the Global HERG Screening market is the increased focus on drug safety. This growing concern encourages companies to allocate resources towards the development of sophisticated screening technologies that can identify potential compounds with harmful cardiac effects early in the drug discovery process. By prioritizing the identification of safety risks, organizations aim to ensure the efficacy and reliability of their drug candidates, thereby fostering a safer pharmaceutical environment. As a result, the demand for enhanced HERG screening solutions continues to rise, reflecting the industry's commitment to prioritizing patient safety and regulatory compliance throughout the drug development lifecycle.

Restraints in the Global HERG Screening Market

One of the significant limitations in the global hERG screening market is the substantial financial burden associated with purchasing and maintaining advanced screening equipment, such as automated patch clamp systems. This high initial investment poses a particular challenge for smaller pharmaceutical companies and research institutions, hindering their ability to access and utilize the latest hERG screening technologies. As a result, these financial constraints may restrict their research capabilities and slow down the development of new drugs, ultimately impacting their competitiveness in the market. This situation creates a barrier for innovation and technological advancement within the industry.

Market Trends of the Global HERG Screening Market

The Global hERG Screening market is witnessing a notable trend towards heightened consumer awareness and the growing preference for clean label products, prompting pharmaceutical and biotechnology companies to enhance their compound screening processes. The adoption of Automated Patch Clamp Systems is gaining momentum due to their superior throughput capabilities and precise measurements, essential for identifying hERG liabilities efficiently. Additionally, the emphasis on High-Throughput Screening (HTS) technology is reshaping the landscape, enabling researchers to assess multiple compounds simultaneously, thereby accelerating the screening process. This convergence of innovation and demand for safety is driving market growth and reshaping industry practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global HERG Screening Market Size by Type & CAGR (2025-2032)

• Market Overview
• Gene KCNH2
• Mutant KCNH2

Global HERG Screening Market Size by Ion Channel & CAGR (2025-2032)

• Market Overview
• Voltage-Gated
• Ligand-Gated

Global HERG Screening Market Size by Application & CAGR (2025-2032)

• Market Overview
• Antiarrhythmic
• Antiphyshotic
• Antibiotics
• Others

Global HERG Screening Market Size & CAGR (2025-2032)

• North America (Type, Ion Channel, Application)
  • US
  • Canada
• Europe (Type, Ion Channel, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Ion Channel, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Ion Channel, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Ion Channel, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Cytocentrics AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanion Technologies GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB Drug Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B'SYS GmbH (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RedShift BioAnalytics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Icagen, Inc. (a division of Eurofins DiscoverX) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apredica (a division of Eurofins DiscoverX) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotrem S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axxam S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ncardia AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations